IL94163A - Insulin analogues - Google Patents

Insulin analogues

Info

Publication number
IL94163A
IL94163A IL9416390A IL9416390A IL94163A IL 94163 A IL94163 A IL 94163A IL 9416390 A IL9416390 A IL 9416390A IL 9416390 A IL9416390 A IL 9416390A IL 94163 A IL94163 A IL 94163A
Authority
IL
Israel
Prior art keywords
insulin
leu
cys
analogue
chain
Prior art date
Application number
IL9416390A
Other languages
English (en)
Other versions
IL94163A0 (en
Inventor
Panayotis G Katsoyannis
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Priority to IL11143790A priority Critical patent/IL111437A/en
Publication of IL94163A0 publication Critical patent/IL94163A0/xx
Priority to IL11143794A priority patent/IL111437A0/xx
Publication of IL94163A publication Critical patent/IL94163A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
IL9416390A 1989-04-20 1990-04-22 Insulin analogues IL94163A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL11143790A IL111437A (en) 1989-04-20 1990-04-22 Insulin analogues
IL11143794A IL111437A0 (en) 1989-04-20 1994-10-28 Insulin analogues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34092989A 1989-04-20 1989-04-20

Publications (2)

Publication Number Publication Date
IL94163A0 IL94163A0 (en) 1991-01-31
IL94163A true IL94163A (en) 1995-08-31

Family

ID=23335524

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9416390A IL94163A (en) 1989-04-20 1990-04-22 Insulin analogues

Country Status (15)

Country Link
EP (1) EP0469084B1 (fi)
JP (1) JPH04504858A (fi)
AT (1) ATE120762T1 (fi)
AU (1) AU631868B2 (fi)
CA (1) CA2014896A1 (fi)
DE (1) DE69018461T2 (fi)
FI (1) FI914898A0 (fi)
GR (1) GR1000908B (fi)
HU (1) HU210142B (fi)
IE (1) IE67353B1 (fi)
IL (1) IL94163A (fi)
NO (1) NO301544B1 (fi)
PT (1) PT93832B (fi)
WO (1) WO1990012814A1 (fi)
ZA (1) ZA902965B (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK158390D0 (da) * 1990-07-02 1990-07-02 Novo Nordisk As Nye peptider
DK33591D0 (fi) * 1991-02-27 1991-02-27 Novo Nordisk As
US5268453A (en) * 1991-08-08 1993-12-07 Scios Inc. Tissue-selective insulin analogs
GB9316895D0 (en) * 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
US6024090A (en) 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US5743250A (en) 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US6342225B1 (en) 1993-08-13 2002-01-29 Deutshces Wollforschungsinstitut Pharmaceutical active conjugates
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
AUPP609198A0 (en) * 1998-09-22 1998-10-15 Curtin University Of Technology Use of non-peptidyl compounds for the treatment of insulin related ailments
EP1174437A4 (en) 1999-04-26 2006-03-15 Ajinomoto Kk HORMONAL INHIBITOR STIMULATING MELANOCYTES
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2006019015A1 (ja) * 2004-08-18 2006-02-23 Kaneka Corporation インスリン結合たんぱく質と結合能力のあるペプチドおよび吸着材
WO2007020256A1 (en) 2005-08-16 2007-02-22 Novo Nordisk A/S Method for making mature insulin polypeptides
HUE029512T2 (en) 2006-09-22 2017-03-28 Novo Nordisk As Protease Resistant Insulin Analogs
JP5503968B2 (ja) 2006-09-27 2014-05-28 ノボ・ノルデイスク・エー／エス 成熟インスリンポリペプチドの作製方法
US20110065633A1 (en) 2008-01-30 2011-03-17 Indiana University Research And Technology Corporation Ester-based peptide prodrugs
WO2009112583A2 (en) 2008-03-14 2009-09-17 Novo Nordisk A/S Protease-stabilized insulin analogues
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
CN102245633A (zh) * 2008-12-09 2011-11-16 诺沃—诺迪斯克有限公司 新的胰岛素类似物
CA2744558A1 (en) 2008-12-19 2010-07-15 Indiana University Research And Technology Corporation Amide-based insulin prodrugs
JP5789515B2 (ja) 2008-12-19 2015-10-07 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ インスリン類似体
AU2011268327B2 (en) 2010-06-16 2016-02-25 Indiana University Research And Technology Corporation Single chain insulin agonists exhibiting high activity at the insulin receptor
EP2585102B1 (en) 2010-06-24 2015-05-06 Indiana University Research and Technology Corporation Amide-based insulin prodrugs
WO2013096386A1 (en) 2011-12-20 2013-06-27 Indiana University Research And Technology Corporation Ctp-based insulin analogs for treatment of diabetes
JP6387008B2 (ja) 2012-09-26 2018-09-05 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ インスリンアナローグダイマー
US9670162B2 (en) 2013-03-14 2017-06-06 The Board Of Trustees Of The Leland Stanford Junio Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
RU2678134C2 (ru) 2013-03-14 2019-01-23 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Конъюгаты инсулин-инкретин
WO2015052088A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
EP3206710B1 (en) 2014-09-24 2020-05-06 Indiana University Research & Technology Corporation Incretin-insulin conjugates
ES2947409T3 (es) 2014-09-24 2023-08-08 Univ Indiana Res & Tech Corp Profármacos de insulina a base de amida lipídica
HRP20221324T1 (hr) 2016-12-16 2022-12-23 Novo Nordisk A/S Farmaceutski pripravci koji sadrže inzulin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation

Also Published As

Publication number Publication date
JPH04504858A (ja) 1992-08-27
EP0469084B1 (en) 1995-04-05
IE67353B1 (en) 1996-03-20
EP0469084A1 (en) 1992-02-05
NO914085L (no) 1991-11-28
GR1000908B (el) 1993-03-16
HU210142B (en) 1995-02-28
DE69018461T2 (de) 1995-08-03
DE69018461D1 (de) 1995-05-11
PT93832A (pt) 1990-11-20
HUT59941A (en) 1992-07-28
IE901404L (en) 1990-10-20
NO301544B1 (no) 1997-11-10
ZA902965B (en) 1991-02-27
FI914898A0 (fi) 1991-10-17
HU903398D0 (en) 1991-12-30
IL94163A0 (en) 1991-01-31
WO1990012814A1 (en) 1990-11-01
PT93832B (pt) 1996-09-30
NO914085D0 (no) 1991-10-17
CA2014896A1 (en) 1990-10-20
AU5541590A (en) 1990-11-16
AU631868B2 (en) 1992-12-10
GR900100290A (en) 1991-09-27
ATE120762T1 (de) 1995-04-15

Similar Documents

Publication Publication Date Title
AU631868B2 (en) Hepatospecific insulin analogues
Schwartz et al. A superactive insulin:[B10-aspartic acid] insulin (human).
FI79786C (fi) Foerfarande foer framstaellning ett farmaceutiskt medel foer behandling av diabetes.
US4650787A (en) Biologically active octapeptides
US3904594A (en) Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US4992417A (en) Superactive human insulin analogues
Spiess et al. Multiple forms of somatostatin-like activity in rat hypothalamus
US4699897A (en) Biologically active peptides structurally related to regions within growth hormones
EP0382732B1 (en) Superactive human insulin analogues
US5208217A (en) Hepatospecific insulin analogues
EP0155786B1 (en) New peptide, and production and use thereof
REAGAN et al. Isolation and biological characterization of fragments of human growth hormone produced by digestion with plasmin
US4657891A (en) Diuretic peptide, and production and use thereof
IL111437A (en) Insulin analogues
AU669636B2 (en) Amylin antagonists and agonists
Ferderigos et al. The effect of modifications of the A 5 and A 19 amino acid residues on the biological activity of insulin.[Leu 5-A] and [Phe 19-A] sheep insulins
CA1338584C (en) Superactive human insulin analogues
HRP940839A2 (en) Short peptides having the effect of insulin
HU211312A9 (hu) Májspecifikus inzulinanalógok Az átmeneti oltalom az 1-9. igénypontokra vonatkozik.

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void